Additionally, they demonstrate increased naïve and effector memory T cells, as well as enhanced CD57/CD73 expression in lymphocytes compared to healthy controls, which may contribute to the pathogenesis of neurocognitive impairment in DM. The gene discussed is B3GAT1; the disease is dermatomyositis.